Phase II trial of flavopiridol, a cyclin dependent kinase inhibitor, in untreated metastatic malignant melanoma
Susan Burdette-Radoux, Richard G. Tozer, Reinhard C. Lohmann, Ian Quirt, D. Scott Ernst, Wendy Walsh, Nancy Wainman, A. Dimitrios Colevas, Elizabeth A. EisenhauerVolume:
22
Language:
english
Pages:
8
DOI:
10.1023/b:drug.0000026258.02846.1c
Date:
August, 2004
File:
PDF, 70 KB
english, 2004